Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest
A Randomized Controlled Trial on Early Double External Sequential Defibrillation in Out of Hospital Cardiac Arrest
St. Olavs Hospital
356 participants
Apr 28, 2025
INTERVENTIONAL
Conditions
Summary
Double Sequential External Defibrillation (DSED) represents an alternative treatment of refractory ventricular fibrillation (rVF) in out-of-hospital cardiac arrest (OHCA). The procedure consists of two defibrillators that administer shocks at the same time. Currently, the procedure is not initiated before at least three failed attempts with one defibrillator. This can delay the potential benefits of establishing DSED earlier in the treatment. Studies have shown that early defibrillation is crucial for survival in OHCA patients, and in 2022, a clinical trial showed that survival in patients treated with DSED was higher compared to standard treatment. The effect of initiating OHCA treatment is unknown. The DUALDEFIB trial seeks to investigate if treating OHCA patients with DSED as an initial treatment will increase survival and provide improved neurological outcome.
Eligibility
Inclusion Criteria1
- Patients with out of hospital cardiac arrest presenting with a shockable rhythm
Exclusion Criteria4
- Age below 18 years
- Obvious or suspected pregnancy
- Incarcerated patients
- Preexisting do-not-resuscitate order
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DSED procedure consists of pads placed in anterior-lateral position, and in anterior-posterior position. Defibrillations will be given in rapid sequence, less than a second apart. All other aspects of resuscitation in accordance to existing guidelines.
Standard OHCA treatment according to existing guidelines.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06672159